EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis

Sedighe Hooshmandi, Ehsan Jangholi, Amirreza Heidarian, Mahsa Dehghani, Ali Ghassemi, Aida Heidary, Ali Rezvanimehr, Erfan Sadeghi, Seyed Mohammad Ghodsi, Mohammad Hoseinian, Mostafa Farzin, Hamid Zaferani Arani und 1 weitere

Precision Medical Sciences · 2025-06 · 14 (2) · 66-74

DOI: 10.1002/prm2.70003 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Precision Medical Sciences, online erschienen am 10.06.2025. Verfasst von Sedighe Hooshmandi und 12 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) is a common central nervous system malignancy with poor survival despite new treatments. Although some evidence demonstrated the prognostic effects of metastasis‐associated lung adenocarcinoma transcript 1 ( MALAT1 ) and urothelial carcinoma associated 1 ( UCA1 ) long non‐coding RNAs (lncRNAs) in patients with GBM, a comprehensive study has not yet evaluated the clinical importance of these lncRNAs. Hence, this review aimed to predict the significance of expressions of MALAT and UCA1 lncRNAs in patients with GBM. Using proper keywords, a thorough literature search was performed via databases, including PubMed, Web of Knowledge, Scopus, and EMBASE until December 2024. The relationship between lncRNA expressions and overall survival (OS) in patients with GBM was assessed using hazard ratios (HR) and confidence intervals (95% CI), and the fixed and random effects models were used to estimate the pooled effect size. Also, the Newcastle‐Ottawa Quality Assessment Scale was used as an appraisal tool. Among 1553 initially founded records, 13 studies were enrolled in the final analysis, consisting of 915 and 257 samples in the MALAT1 and UCA1 groups, respectively. Compared to the patients with low expression, those with high expression of MALAT1 had a mortality risk of 80% (HR = 1.8, 95% CI = [1.39, 2.33], p = .001). Additionally, the impact of UCA1 expression on patient prognosis indicated that lower OS among patients was correlated with high expression of UCA1 ; however, the meta‐analysis was not performed for UCA1 due to a lack of adequate studies. According to our findings, high expression of MALAT1 was correlated with poor prognosis in patients with GBM.

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Hooshmandi, S., Jangholi, E., Heidarian, A., Dehghani, M., Ghassemi, A., Heidary, A., Rezvanimehr, A., Sadeghi, E., Ghodsi, S. M., Hoseinian, M., Farzin, M., Arani, H. Z., & Hadjighassem, M. (2025). The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis. Precision Medical Sciences, 14(2), 66-74. https://doi.org/10.1002/prm2.70003

Vancouver

Hooshmandi S, Jangholi E, Heidarian A, Dehghani M, Ghassemi A, Heidary A, et al. The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis. Precision Medical Sciences. 2025;14(2):66-74. doi:10.1002/prm2.70003

BibTeX
@article{Hooshmandi2025,
  author = {Hooshmandi, Sedighe and Jangholi, Ehsan and Heidarian, Amirreza and Dehghani, Mahsa and Ghassemi, Ali and Heidary, Aida and Rezvanimehr, Ali and Sadeghi, Erfan and Ghodsi, Seyed Mohammad and Hoseinian, Mohammad and Farzin, Mostafa and Arani, Hamid Zaferani and Hadjighassem, Mahmoudreza},
  title = {The role of MALAT1 and UCA1 long non‐coding RNAs on the prognosis of patients with glioblastoma: A systematic review and meta‐analysis},
  journal = {Precision Medical Sciences},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {66--74},
  doi = {10.1002/prm2.70003}
}
Kostenlos starten →